Lotus Eye Hospital & Institute Ltd

LOTUSEYE

Watchlist

AI Mode

‌

Market Cap

₹ 273 Cr

P/E

410.16

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

OVERVALUED

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bullish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Lotus Eye Hospital & Institute Ltd is a renowned eye care hospital group situated in South India, specializing in super-specialty services related to ophthalmology.

The company operates seven centers across major cities, offering advanced eye care through cutting-edge technologies like LASIK and Zyoptix, backed by expert ophthalmologists.

Lotus Eye Hospital was the first in South East Asia to implement Epilasik technology and has consistently introduced advanced ophthalmic procedures.

It maintains a total bed capacity of 120 across its centers, focusing predominantly on outpatient and day-care surgeries.

The hospital's operations are characterized by high-tech equipments, ensuring top-tier eye care with a well-trained paramedical and administrative workforce.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

273 Cr

Volatility

Moderate Risk

P/E Ratio

410.2

Industry P/E

62.6

PEG Ratio

—

P/B Ratio

4.5

52W High

140.90

52W Low

55.31

Sales CAGR

2.80%

8.40%

4.09%

10Y

5.30%

Profit CAGR

-74.57%

-37.20%

-7.03%

10Y

24.78%

ROE

TTM

1.11%

4.37%

4.32%

10Y

3.05%

ROCE

TTM

2.57%

6.43%

6.17%

10Y

4.11%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ASARFI	188.10	378 Cr	27.79	4.28	0.00	15.39	17.02	7.89
LOTUSEYE	131.70	273 Cr	410.16	4.50	0.00	1.11	2.57	0.94
AASHKA	83.50	215 Cr	92.00	2.16	0.00	1.13	2.34	2.08
NEPHROCARE	120.50	195 Cr	68.02	3.65	0.00	6.13	8.59	5.07
MAITREYA	226.40	157 Cr	84.42	5.87	0.00	0.52	4.98	0.33
FORTISMLR	61.01	116 Cr	25.48	3.36	0.00	13.19	14.48	12.18
AAKAAR	79.50	108 Cr	17.84	2.15	0.00	0.00	0.00	-1.10

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	13	13	12	11	13	13	12	12	14	13
Expenses	10	11	10	10	11	12	11	12	12	12
Operating Profit	2.38	1.81	1.58	0.75	1.67	1.15	0.80	-0.17	1.48	0.78
OPM %	18.93	14.22	13.13	6.89	12.96	8.91	6.53	-1.48	10.95	5.98
Other Income	0.30	0.28	0.34	0.40	0.31	0.26	0.22	0.52	0.19	0.27
Interest	0.02	0.01	0.04	0.03	0.06	0.08	0.13	0.09	0.12	0.12
Depreciation	0.73	0.89	0.98	1.12	1.06	1.23	1.31	-0.58	0.82	0.85
Profit Before Tax	1.93	1.19	0.90	0.01	0.86	0.11	-0.43	0.84	0.73	0.07
Tax %	27.98	28.57	26.67	-200.00	26.74	9.09	44.19	70.24	26.03	-57.14
Net Profit	1.38	0.85	0.66	0.02	0.62	0.10	-0.24	0.25	0.54	0.12
EPS in Rs	0.67	0.41	0.32	0.01	0.30	0.05	-0.11	0.12	0.26	0.06

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	34	38	38	41	32	39	47	48	50	50
Expenses	31	34	35	37	29	33	39	42	46	47
Operating Profit	3.24	4.22	3.07	3.81	3.55	5.85	7.59	6.53	3.43	3.26
OPM %	9.55	11.10	8.00	9.41	10.96	15.03	16.13	13.55	6.93	6.50
Other Income	0.68	0.91	0.68	0.21	0.83	0.88	1.14	1.31	1.31	1.19
Interest	0.06	0.05	0.06	0.07	0.06	0.13	0.10	0.10	0.36	0.42
Depreciation	3.44	3.37	3.06	2.50	2.33	2.50	2.98	3.73	3.01	2.78
Profit Before Tax	0.42	1.70	0.63	1.46	1.99	4.09	5.65	4.01	1.38	1.25
Tax %	-6.14	-2.60	-12.77	26.86	21.29	27.10	27.86	27.39	46.53	48.00
Net Profit	0.44	1.75	0.71	1.06	1.57	2.98	4.08	2.91	0.74	0.65
EPS in Rs	0.21	0.84	0.33	0.51	0.76	1.44	1.96	1.41	0.36	0.33
Dividend Payout %	238.10	59.52	0.00	0.00	66.67	34.72	25.51	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	21	21	21	21	21	21	21	21	21	21
Reserves	29	29	30	29	30	32	34	37	39	39
Borrowings	0.48	0.30	0.09	0.09	0.00	0.40	1.24	0.67	1.11	3.43
Other Liabilities	4.86	4.59	7.48	6.31	6.85	6.13	5.76	4.94	6.11	6.14
Total Liabilities	55	55	58	57	58	59	62	63	67	70
Fixed Assets	44	41	43	44	43	41	44	44	49	54
CWIP	0.42	0.65	0.29	0.29	0.00	0.00	0.00	0.00	0.08	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	11	13	15	12	15	19	18	19	18	16
Total Assets	55	55	58	57	58	59	62	63	67	70

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	3.38	2.97	5.78	4.20	4.97	2.73	4.41	4.39	5.68	2.70
Cash from Investing Activity	-0.85	-1.06	-3.86	-4.01	-0.68	0.49	-3.94	-2.19	-4.63	-6.13
Cash from Financing Activity	-0.58	-0.25	-1.51	-1.41	0.13	-0.32	-1.58	-1.71	-3.40	-1.60
Net Cash Flow	1.96	1.66	0.41	-1.22	4.42	2.90	-1.10	0.49	-2.35	-5.03

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	58.14%	58.17%	58.43%	57.58%	56.58%	41.40%	40.24%	40.03%	40.14%	40.22%	40.39%	40.64%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.03%	0.04%	0.04%	0.03%	0.02%
Public	41.86%	41.83%	41.57%	42.42%	43.42%	58.60%	59.75%	59.94%	59.82%	59.74%	59.58%	59.33%
Total Shareholders	7,416	7,345	7,425	7,660	8,314	12,502	11,759	12,514	11,734	11,508	11,121	10,777

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Sep 01, 2025	. thomas santosh	Bulk	Buy	123.94	1.55 Cr	1,24,682	0.59
Mar 18, 2025	. vramath financial service...	Bulk	Buy	58.07	0.66 Cr	1,13,269	0.54
Aug 20, 2024	. vramath financial service...	Bulk	Buy	80.60	1.62 Cr	2,00,409	0.96
Jul 12, 2024	. vramath financial service...	Bulk	Buy	65.27	0.86 Cr	1,31,328	0.63
Jul 12, 2024	. vramath financial service...	Bulk	Sell	68.94	0.22 Cr	31,328	0.15
Jul 06, 2024	S rajkumar	Insider - Promoter	Disposal	57.19	0.75 Cr	1,30,934	0.62
Jun 20, 2024	S rajkumar	Insider - Promoter	Disposal	57.04	0.62 Cr	1,09,489	0.52
Mar 12, 2024	S rajkumar	Insider - Promoter	Disposal	54.87	17.33 Cr	31,58,191	15.1
Mar 11, 2024	Rajeev choudhary	Bulk	Buy	66.20	0.79 Cr	1,20,000	0.57
Mar 06, 2024	Nk securities research privat...	Bulk	Sell	68.31	1.51 Cr	2,20,779	1.06

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q1 FY22

Investor Presentation

Q3 FY21

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	13	13	12	11	13	13	12	12	14	13
Expenses	10	11	10	10	11	12	11	12	12	12
Operating Profit	2.38	1.81	1.58	0.75	1.67	1.15	0.80	-0.17	1.48	0.78
OPM %	18.93	14.22	13.13	6.89	12.96	8.91	6.53	-1.48	10.95	5.98
Other Income	0.30	0.28	0.34	0.40	0.31	0.26	0.22	0.52	0.19	0.27
Interest	0.02	0.01	0.04	0.03	0.06	0.08	0.13	0.09	0.12	0.12
Depreciation	0.73	0.89	0.98	1.12	1.06	1.23	1.31	-0.58	0.82	0.85
Profit Before Tax	1.93	1.19	0.90	0.01	0.86	0.11	-0.43	0.84	0.73	0.07
Tax %	27.98	28.57	26.67	-200.00	26.74	9.09	44.19	70.24	26.03	-57.14
Net Profit	1.38	0.85	0.66	0.02	0.62	0.10	-0.24	0.25	0.54	0.12
EPS in Rs	0.67	0.41	0.32	0.01	0.30	0.05	-0.11	0.12	0.26	0.06

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	34	38	38	41	32	39	47	48	50	50
Expenses	31	34	35	37	29	33	39	42	46	47
Operating Profit	3.24	4.22	3.07	3.81	3.55	5.85	7.59	6.53	3.43	3.26
OPM %	9.55	11.10	8.00	9.41	10.96	15.03	16.13	13.55	6.93	6.50
Other Income	0.68	0.91	0.68	0.21	0.83	0.88	1.14	1.31	1.31	1.19
Interest	0.06	0.05	0.06	0.07	0.06	0.13	0.10	0.10	0.36	0.42
Depreciation	3.44	3.37	3.06	2.50	2.33	2.50	2.98	3.73	3.01	2.78
Profit Before Tax	0.42	1.70	0.63	1.46	1.99	4.09	5.65	4.01	1.38	1.25
Tax %	-6.14	-2.60	-12.77	26.86	21.29	27.10	27.86	27.39	46.53	48.00
Net Profit	0.44	1.75	0.71	1.06	1.57	2.98	4.08	2.91	0.74	0.65
EPS in Rs	0.21	0.84	0.33	0.51	0.76	1.44	1.96	1.41	0.36	0.33
Dividend Payout %	238.10	59.52	0.00	0.00	66.67	34.72	25.51	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	21	21	21	21	21	21	21	21	21	21
Reserves	29	29	30	29	30	32	34	37	39	39
Borrowings	0.48	0.30	0.09	0.09	0.00	0.40	1.24	0.67	1.11	3.43
Other Liabilities	4.86	4.59	7.48	6.31	6.85	6.13	5.76	4.94	6.11	6.14
Total Liabilities	55	55	58	57	58	59	62	63	67	70
Fixed Assets	44	41	43	44	43	41	44	44	49	54
CWIP	0.42	0.65	0.29	0.29	0.00	0.00	0.00	0.00	0.08	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	11	13	15	12	15	19	18	19	18	16
Total Assets	55	55	58	57	58	59	62	63	67	70

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	3.38	2.97	5.78	4.20	4.97	2.73	4.41	4.39	5.68	2.70
Cash from Investing Activity	-0.85	-1.06	-3.86	-4.01	-0.68	0.49	-3.94	-2.19	-4.63	-6.13
Cash from Financing Activity	-0.58	-0.25	-1.51	-1.41	0.13	-0.32	-1.58	-1.71	-3.40	-1.60
Net Cash Flow	1.96	1.66	0.41	-1.22	4.42	2.90	-1.10	0.49	-2.35	-5.03

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ASARFI	188.10	378 Cr	27.79	4.28	0.00	15.39	17.02	7.89
LOTUSEYE	131.70	273 Cr	410.16	4.50	0.00	1.11	2.57	0.94
AASHKA	83.50	215 Cr	92.00	2.16	0.00	1.13	2.34	2.08
NEPHROCARE	120.50	195 Cr	68.02	3.65	0.00	6.13	8.59	5.07
MAITREYA	226.40	157 Cr	84.42	5.87	0.00	0.52	4.98	0.33
FORTISMLR	61.01	116 Cr	25.48	3.36	0.00	13.19	14.48	12.18
AAKAAR	79.50	108 Cr	17.84	2.15	0.00	0.00	0.00	-1.10

Overview

Detailed Summary

Lotus Eye Hospital & Institute Ltd is a renowned eye care hospital group situated in South India, specializing in super-specialty services related to ophthalmology.

The company operates seven centers across major cities, offering advanced eye care through cutting-edge technologies like LASIK and Zyoptix, backed by expert ophthalmologists.

Lotus Eye Hospital was the first in South East Asia to implement Epilasik technology and has consistently introduced advanced ophthalmic procedures.

It maintains a total bed capacity of 120 across its centers, focusing predominantly on outpatient and day-care surgeries.

The hospital's operations are characterized by high-tech equipments, ensuring top-tier eye care with a well-trained paramedical and administrative workforce.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

273 Cr

Volatility

Moderate Risk

P/E Ratio

410.2

Industry P/E

62.6

PEG Ratio

—

P/B Ratio

4.5

52W High

140.90

52W Low

55.31

Sales CAGR

2.80%

8.40%

4.09%

10Y

5.30%

Profit CAGR

-74.57%

-37.20%

-7.03%

10Y

24.78%

ROE

TTM

1.11%

4.37%

4.32%

10Y

3.05%

ROCE

TTM

2.57%

6.43%

6.17%

10Y

4.11%